INSERM, UMR 1287, Gustave Roussy, Equipe Labellisée LNCC, Villejuif, France.
Université Paris Saclay, UMR 1287, Gustave Roussy, Villejuif, France.
Small GTPases. 2021 Sep-Nov;12(5-6):399-415. doi: 10.1080/21541248.2021.1885134. Epub 2021 Feb 11.
Megakaryocytes (MKs) are the bone marrow (BM) cells that generate blood platelets by a process that requires: i) polyploidization responsible for the increased MK size and ii) cytoplasmic organization leading to extension of long pseudopods, called proplatelets, through the endothelial barrier to allow platelet release into blood. Low level of localized RHOA activation prevents actomyosin accumulation at the cleavage furrow and participates in MK polyploidization. In the platelet production, RHOA and CDC42 play opposite, but complementary roles. RHOA inhibits both proplatelet formation and MK exit from BM, whereas CDC42 drives the development of the demarcation membranes and MK migration in BM. Moreover, the or MK specific knock-out in mice and the genetic alterations in their down-stream effectors in human induce a thrombocytopenia demonstrating their key roles in platelet production. A better knowledge of Rho-GTPase signalling is thus necessary to develop therapies for diseases associated with platelet production defects. AKT: Protein Kinase BARHGEF2: Rho/Rac Guanine Nucleotide Exchange Factor 2ARP2/3: Actin related protein 2/3BM: Bone marrowCDC42: Cell division control protein 42 homologCFU-MK: Colony-forming-unit megakaryocyteCIP4: Cdc42-interacting protein 4mDIA: DiaphanousDIAPH1; Protein diaphanous homolog 1ECT2: Epithelial Cell Transforming Sequence 2FLNA: Filamin AGAP: GTPase-activating proteins or GTPase-accelerating proteinsGDI: GDP Dissociation InhibitorGEF: Guanine nucleotide exchange factorHDAC: Histone deacetylaseLIMK: LIM KinaseMAL: Megakaryoblastic leukaemiaMARCKS: Myristoylated alanine-rich C-kinase substrateMKL: Megakaryoblastic leukaemiaMLC: Myosin light chainMRTF: Myocardin Related Transcription FactorOTT: One-Twenty Two ProteinPACSIN2: Protein Kinase C And Casein Kinase Substrate In Neurons 2PAK: P21-Activated KinasePDK: Pyruvate Dehydrogenase kinasePI3K: Phosphoinositide 3-kinasePKC: Protein kinase CPTPRJ: Protein tyrosine phosphatase receptor type JRAC: Ras-related C3 botulinum toxin substrate 1RBM15: RNA Binding Motif Protein 15RHO: Ras homologousROCK: Rho-associated protein kinaseSCAR: Suppressor of cAMP receptorSRF: Serum response factorSRC: SarcTAZ: Transcriptional coactivator with PDZ motifTUBB1: Tubulin β1VEGF: Vascular endothelial growth factorWAS: Wiskott Aldrich syndromeWASP: Wiskott Aldrich syndrome proteinWAVE: WASP-family verprolin-homologous proteinWIP: WASP-interacting proteinYAP: Yes-associated protein.
巨核细胞(MKs)是骨髓(BM)细胞,通过一个过程产生血小板,该过程需要:i)多倍化负责增加 MK 的大小和 ii)细胞质组织导致长伪足的延伸,称为前血小板,穿过内皮屏障允许血小板释放到血液中。局部 RHOA 活性的低水平可防止肌动球蛋白在分裂沟处积累,并参与 MK 多倍化。在血小板生成中,RHOA 和 CDC42 发挥相反但互补的作用。RHOA 抑制前血小板的形成和 MK 从 BM 中排出,而 CDC42 驱动分界膜的发育和 MK 在 BM 中的迁移。此外,在小鼠中敲除或敲除 或 MK 特异性敲除及其下游效应物的遗传改变会导致血小板减少症,证明它们在血小板生成中的关键作用。因此,更好地了解 Rho-GTPase 信号对于开发与血小板生成缺陷相关疾病的治疗方法是必要的。AKT:蛋白激酶BARHGEF2:Rho/Rac 鸟嘌呤核苷酸交换因子 2ARP2/3:肌动蛋白相关蛋白 2/3BM:骨髓CDC42:细胞分裂控制蛋白 42 同源物 CFU-MK:集落形成单位巨核细胞 CIP4:CDC42 相互作用蛋白 4 mDIA:Diaphanous DIAPH1;蛋白 diaphanous 同源物 1ECT2:上皮细胞转化序列 2FLNA:细丝蛋白 AGAP:GTPase 激活蛋白或 GTPase 加速蛋白 GDI:GDP 解离抑制剂 GEF:鸟嘌呤核苷酸交换因子 HDAC:组蛋白去乙酰化酶 LIMK:LIM 激酶 MAL:巨核母细胞白血病 MARCKS:肌球蛋白相关 C 激酶底物 MKL:巨核母细胞白血病 MLC:肌球蛋白轻链 MRTF:肌球蛋白相关转录因子 OTT:One-Twenty Two 蛋白 PACSIN2:蛋白激酶 C 和酪蛋白激酶底物在神经元 2 中 PAK:P21 激活激酶 PDK:丙酮酸脱氢酶激酶 PI3K:磷酸肌醇 3-激酶 PKC:蛋白激酶 C PTPRJ:蛋白酪氨酸磷酸酶受体型 J RAC:Ras 相关 C3 肉毒杆菌毒素底物 1 RBM15:RNA 结合基序蛋白 15 RHO:Ras 同源物 ROCK:Rho 相关蛋白激酶 SCAR:抑制环 AMP 受体的蛋白 SRF:血清反应因子 SRC:Sarc TAZ:具有 PDZ 基序的转录共激活因子 TUBB1:微管蛋白β1 VEGF:血管内皮生长因子 WAS:Wiskott Aldrich 综合征 WASP:Wiskott Aldrich 综合征蛋白 WAVE:WASP 家族 verprolin 同源蛋白 WIP:WASP 相互作用蛋白 YAP:Yes 相关蛋白。